GlassScriptPhysician profile
Ashley Hall
NPI 1366733396
$2,428.01
in general payments reported to CMS, 2019-2025
19 companies · $544 in 2025
The $544 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $353 · 2022: $699 · 2023: $371 · 2024: $461 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.05 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $600.87 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $536.68 | 2021-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $161.26 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $148.67 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $138.09 | 2023-2025 | Menopur |
| Daiichi Sankyo INC. | $106.64 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $102.99 | 2021-2025 | Airsupra |
| Amgen INC. | $99.22 | 2023-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $96.19 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $90.91 | 2024 | |
| Glaxosmithkline, LLC. | $90.78 | 2021-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $86.68 | 2021-2025 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $51.46 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.61 | 2022 | |
| Boston Scientific Corporation | $30.34 | 2025 | Watchman Flx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $14.79 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $14.26 | 2022 | |
| Amarin Pharma, INC. | $13.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.